SCHEMBL2937759

SCHEMBL2937759

O=C1[C@@H](Cc2csc3ccccc23)N(Cc2ccncc2)C(=O)N1c1ccc(S(=O)(=O)C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.50
HDAC6 Q9UBN7 1/20 0.34
PTGS2 P35354 3/20 0.33
KMT2A Q03164 2/20 0.33
PTGS1 P23219 1/20 0.33
SMO Q99835 2/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
GAA P10253 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
CA9 Q16790 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937762 1.00 IGF1R (0.50) IGF1RHDAC6PTGS2KMT2APTGS1
Trifluoroacetic Acid SCHEMBL3723547 0.95 IGF1R (0.46) IGF1RHDAC6KMT2ASMOTP53
SCHEMBL2937103 0.87 IGF1R (0.69) IGF1RPTGS2KMT2APTGS1MAPT
SCHEMBL2937105 0.87 IGF1R (0.69) IGF1RPTGS2KMT2APTGS1MAPT
SCHEMBL2940931 0.85 IGF1R (0.50) IGF1RHDAC6SMOTP53GAA
SCHEMBL2940925 0.85 IGF1R (0.50) IGF1RHDAC6SMOTP53GAA
Trifluoroacetic Acid SCHEMBL3730823 0.83 IGF1R (0.63) IGF1RKMT2APTGDR2MEN1
Trifluoroacetic Acid SCHEMBL3728810 0.81 IGF1R (0.42) IGF1RHDAC6KMT2ATP53MAPT
Trifluoroacetic Acid SCHEMBL3724828 0.81 HDAC6 (0.47) IGF1RHDAC6SMOTP53GAA
SCHEMBL2939939 0.79 IGF1R (0.44) IGF1RHDAC6KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed